Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Losartan in the Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients.

NCT06135493 is registered in ClinicalTrials.gov with Future University in Egypt as lead sponsor.

NCT NCT06135493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06135493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Losartan in the Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients.
Lead sponsor
Future University in Egypt
Phase
Phase 2
Overall status
Completed
Start date
December 12, 2023
Completion date
March 30, 2025
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy due to chemotherapy